Monitoring for metabolic complications associated with atypical antipsychotics.
Farver
Debra
D
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000145:classification / Q000627:therapeutic use; D016903:Drug Monitoring; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D006949:Hyperlipidemias / Q000139:chemically induced; D008659:Metabolic Diseases / Q000139:chemically induced*; D012559:Schizophrenia / Q000188:drug therapy*; D015430:Weight Gain
D014150:Antipsychotic Agents